Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

The identification of the optimal cancer treatment has become progressively more intricate for non-small-cell lung cancer (NSCLC) patients due to the multitude of options available. The testing of biomarkers to predict clinical responses to therapies is pivotal to stratify the patients based on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Normanno, Nicola, Barberis, Massimo, De Marinis, Filippo, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352587/
https://www.ncbi.nlm.nih.gov/pubmed/32575424
http://dx.doi.org/10.3390/cancers12061627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352587/
https://www.ncbi.nlm.nih.gov/pubmed/32575424
http://dx.doi.org/10.3390/cancers12061627

Ejemplares similares